Arcus Biosciences Inc (RCUS)
US Market

Arcus Biosciences (RCUS) Stock Price & Analysis


RCUS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$15.70 - $36.13
Previous Close$22.03
Average Volume (3M)1.03M
Market Cap
Enterprise Value$656.52M
Total Cash (Recent Filing)$954.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.7
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.85
Shares Outstanding73,105,580
10 Day Avg. Volume1,266,446
30 Day Avg. Volume1,031,715
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)2.24
Price to Sales (P/S)64.42
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.52
Enterprise Value/Gross Profit5.86
Enterprise Value/Ebitda-2.29
Price Target Upside104.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Arcus Biosciences Inc’s price range in the past 12 months?
Arcus Biosciences Inc lowest stock price was $15.70 and its highest was $36.13 in the past 12 months.
    What is Arcus Biosciences Inc’s market cap?
    Currently, no data Available
    When is Arcus Biosciences Inc’s upcoming earnings report date?
    Arcus Biosciences Inc’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
      How were Arcus Biosciences Inc’s earnings last quarter?
      Arcus Biosciences Inc released its earnings results on May 09, 2023. The company reported -$1.09 earnings per share for the quarter, beating the consensus estimate of -$1.164 by $0.074.
        Is Arcus Biosciences Inc overvalued?
        According to Wall Street analysts Arcus Biosciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Arcus Biosciences Inc pay dividends?
          Arcus Biosciences Inc does not currently pay dividends.
          What is Arcus Biosciences Inc’s EPS estimate?
          Arcus Biosciences Inc’s EPS estimate is -$1.15.
            How many shares outstanding does Arcus Biosciences Inc have?
            Arcus Biosciences Inc has 73,105,580 shares outstanding.
              What happened to Arcus Biosciences Inc’s price movement after its last earnings report?
              Arcus Biosciences Inc reported an EPS of -$1.09 in its last earnings report, beating expectations of -$1.164. Following the earnings report the stock price went down -3.041%.
                Which hedge fund is a major shareholder of Arcus Biosciences Inc?
                Among the largest hedge funds holding Arcus Biosciences Inc’s share is Invus Financial Advisors, LLC. It holds Arcus Biosciences Inc’s shares valued at 29M.


                  Arcus Biosciences Stock Smart Score

                  The Arcus Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Arcus Biosciences Inc

                  Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.


                  Top 5 ETFs holding RCUS

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Fidelity MSCI Health Care Index ETF
                  Loncar Cancer Immunotherapy ETF
                  Up to five ETFs with an Outperform Smart Score that hold RCUS. The ETFs are listed according to market value of RCUS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ultragenyx Pharmaceutical
                  ACADIA Pharmaceuticals
                  SAGE Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis